Sanofi Research And Ddevelopement To Revenue from 2010 to 2024
| SNY Stock | USD 48.67 0.15 0.31% |
Research And Ddevelopement To Revenue | First Reported 2010-12-31 | Previous Quarter 0.15614117 | Current Value 0.19 | Quarterly Volatility 0.01428776 |
Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi main balance sheet or income statement drivers, such as Depreciation And Amortization of 4 B, Interest Expense of 1.1 B or Selling General Administrative of 11.2 B, as well as many exotic indicators such as Price To Sales Ratio of 3.96, Dividend Yield of 0.0232 or PTB Ratio of 1.44. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.
Sanofi | Research And Ddevelopement To Revenue |
Latest Sanofi ADR's Research And Ddevelopement To Revenue Growth Pattern
Below is the plot of the Research And Ddevelopement To Revenue of Sanofi ADR over the last few years. It is the ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services. Sanofi ADR's Research And Ddevelopement To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanofi ADR's overall financial position and show how it may be relating to other accounts over time.
| Research And Ddevelopement To Revenue | 10 Years Trend |
|
Research And Ddevelopement To Revenue |
| Timeline |
Sanofi Research And Ddevelopement To Revenue Regression Statistics
| Arithmetic Mean | 0.15 | |
| Geometric Mean | 0.15 | |
| Coefficient Of Variation | 9.32 | |
| Mean Deviation | 0.01 | |
| Median | 0.15 | |
| Standard Deviation | 0.01 | |
| Sample Variance | 0.0002 | |
| Range | 0.0536 | |
| R-Value | 0.50 | |
| Mean Square Error | 0.0002 | |
| R-Squared | 0.25 | |
| Significance | 0.06 | |
| Slope | 0 | |
| Total Sum of Squares | 0 |
Sanofi Research And Ddevelopement To Revenue History
About Sanofi ADR Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Sanofi ADR income statement, its balance sheet, and the statement of cash flows. Sanofi ADR investors use historical funamental indicators, such as Sanofi ADR's Research And Ddevelopement To Revenue, to determine how well the company is positioned to perform in the future. Although Sanofi ADR investors may use each financial statement separately, they are all related. The changes in Sanofi ADR's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Sanofi ADR's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Sanofi ADR Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Sanofi ADR. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research And Ddevelopement To Revenue | 0.16 | 0.19 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sanofi ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanofi ADR's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanofi Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanofi Adr Stock:Check out the analysis of Sanofi ADR Correlation against competitors. For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Sanofi Stock analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share 1.97 | Revenue Per Share 18.492 | Quarterly Revenue Growth 0.023 | Return On Assets 0.0454 |
The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.